Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma

NCT00005815 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators